FDA rejects Nabriva a second time; Nabriva pins it on travel restrictions
A little over a year after the FDA issued Nabriva its first CRL for the antibiotic Contepo, the agency has issued another.
By Nabriva …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
